Bookoff McAndrews is thrilled to announce the election of Kirsten Johnson to the partnership, effective January 1, 2019. Kirsten has been with the firm since its inception, helping to guide and grow the organization. She has been crucial in helping BoMc launch its chemical, pharmaceutical, and biotechnology practices, and is often consulted as a go-to expert in those fields.

“Since she joined the firm, Kirsten has shown incredible talent,” says Les Bookoff. “It has been a pleasure to watch her develop into a consummate lawyer and professional. She has helped shape our firm values and culture, and drive our success. I am proud to welcome her to the partnership.”

Kirsten brings over a decade of patent experience in strategic portfolio management for diverse areas of technology, from the life sciences to nanotechnology and materials. She works with innovators to develop forward-looking strategies in-line with their business objectives, employing expedited prosecution strategies, patentability assessments, and freedom-to-operate and due diligence analyses. Kirsten leverages particular expertise in chemistry and biotech to advise companies on IP strategies that support R&D investment and the development of new therapeutic products and methods. She routinely coordinates with patent firms across the globe to help clients obtain robust patent protection in the United States and abroad.

BoMc provides high-quality patent prosecution, strategic counseling, and IP transactional representation to sophisticated companies and organizations around the world. With a diverse group of dedicated patent attorneys working together in Washington, D.C., BoMc offers exceptional teamwork, value, and client service.